SEC Filing Details

Luminex® Corporation (NASDAQ: LMNX) develops, manufactures, and markets proprietary biological testing technologies, with applications throughout the life-sciences industry.

SEC Filing Details

Document Details

Form
Filing Date
Mar 1, 2021
Document Date
Feb 25, 2021
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Luminex Corporation
Issuer
LUMINEX CORP
Filer
Bennett Todd C.

Shareholder Tools